echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > AI + Microecological Therapy Blockbuster: Unknown Jun Acquires Ulcerative Colitis Clinical Pipeline

    AI + Microecological Therapy Blockbuster: Unknown Jun Acquires Ulcerative Colitis Clinical Pipeline

    • Last Update: 2022-06-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, the industry-leading AI+ innovative therapy microecological drug research and development company Wuweijun announced that it has acquired the clinical stage drug pipeline M201 project from Assembly Biosciences, Inc.


    The M201 program is designed for patients with mild to moderate ulcerative colitis


    According to Unknown Jun, M201 will be further developed using its drug R&D platform driven by artificial intelligence and big data


    "Unknown Jun has always been committed to developing more advanced treatment methods for ulcerative colitis," said Tan Xian, co-founder and CEO of Unknown Jun.


    It is reported that Unknown Jun has built a top-notch "AI+BT" platform that is scarce in the industry, combining artificial intelligence, biological information analysis and intestinal microecological technology to achieve efficient drug development of "dry and wet combination"


    Through this acquisition, Unknown Jun has harvested the third microecological drug pipeline that has entered the clinical stage


    Since its establishment in 2017, Unknown Jun has expanded the company's operations to 7 cities around the world; recently, Unknown Jun has set up its US headquarters in Cambridge, Massachusetts, which has both corporate operations and laboratory functions


    About unknown gentleman

    About unknown gentleman

    Founded in 2017, Shenzhen Unknown Jun Biotechnology Co.


    Contacts

    Contacts

    Hermione He

    Chief Operating Officer Unknown Jun (US) Chief Operating Officer

    hermionehe@xbiome.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.